New insights on Alzheimer's disease diagnostic.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 22119812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FAD Mutations in Amyloid Precursor Protein Do Not Directly Perturb Intracellular Calcium Homeostasis

  2010cited by this paper
• A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo

  2010cited by this paper
• Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.

  2010cited by this paper
• Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease

  2010cited by this paper
• Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe

  2010cited by this paper
• Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).

  2009cited by this paper
• Low-density lipoprotein receptor-related protein 8 gene polymorphisms and dementia.

  2009cited by this paper
• CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

  2009cited by this paper
• Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

  2009cited by this paper
• Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.

  2008cited by this paper
• Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

  2008cited by this paper
• The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1

  2008cited by this paper
• Longitudinal PIB measures in control, MCI, and AD subjects

  2008cited by this paper
• Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease

  2008cited by this paper
• Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.

  2007cited by this paper
• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

  2007influential reference
• Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis.

  2007cited by this paper
• SPECT imaging in dementia.

  2007cited by this paper
• Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus

  2007cited by this paper
• Role of imaging techniques in the diagnosis of dementia.

  2007cited by this paper
• Tauopathies

  2007cited by this paper
• Genetic variants in brain-derived neurotrophic factor associated with Alzheimer’s disease

  2006cited by this paper
• Candidate genes for late-onset Alzheimer's disease: focus on chromosome 12.

  2006cited by this paper
• Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

  2006cited by this paper
• The Fat of the Land: Do Agricultural Subsidies Foster Poor Health?

  2004cited by this paper
• Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

  2002cited by this paper
• Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neurons

  2002cited by this paper
• Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease

  2002cited by this paper
• Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.

  2001cited by this paper
• Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

  2000cited by this paper
• Staging of Alzheimer-Related Cortical Destruction

  1997cited by this paper
• Staging of Alzheimer-related cortical destruction.

  1997cited by this paper
• A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease

  1997cited by this paper
• AD neuropathology

  1996cited by this paper
• Presenilins and Alzheimer disease

  1995cited by this paper
• Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta/A4 amyloid precursor protein

  1994cited by this paper
• beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

  1992cited by this paper
• Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's disease.

  1991cited by this paper
• β-Amyloid and the pathogenesis of alzheimer's disease

  1991cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper

• The Highlighted Roles of Metabolic and Cellular Response to Stress Pathways Engaged in Circulating hsa-miR-494-3p and hsa-miR-661 in Alzheimer’s Disease

  2020cites this paper
• Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease

  2018influential citation
• Distinguishing Depressive Pseudodementia from Alzheimer Disease: A Comparative Study of Hippocampal Volumetry and Cognitive Tests

  2017cites this paper
• Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats

  2017cites this paper
• Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.

  2016cites this paper
• Sweet old memories: a review of the experimental models of the association between diabetes, senility and dementia

  2016cites this paper
• Developing and Integrating Computer-Aided Diagnostic Tools into Clinical Medicine

  2015cites this paper
• Genomic linkage between Alzheimer's disease and type 2 diabetes.

  2014cites this paper
• Dementia and Depression in Older Adults: A Southeast European Perspective: Summary of a Dementia Psychogeriatric Symposium held in Ohrid, Macedonia, 23 May 2013

  2014cites this paper
• A blood based 12-miRNA signature of Alzheimer disease patients

  2013cites this paper
• Comparative Interactome Investigation of γ-secretase Complex in Alzheimer’s Disease

  2013cites this paper
• Aberrant Functional Organization within and between Resting-State Networks in AD

  2013cites this paper
• The Future of Medical Diagnostics: Large Digitized Databases

  2012cites this paper
• The impairment of insulin signaling in Alzheimer's disease

  2012cites this paper